Actively Recruiting
Comparative Effectiveness of Cold and Warm Water Immersion in Mitigating Delayed Onset Muscle Soreness: a Multi-Arm Randomized Controlled Trial
Led by Józef Piłsudski University of Physical Education · Updated on 2025-02-11
52
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating physical strategies to reduce Delayed Onset Muscle Soreness (DOMS) in healthy, physically active males aged 18 to 25 years. DOMS is a common condition following intense or new physical activity, causing pain, inflammation, and reduced muscle function, peaking within 24 to 72 hours after exercise. The study uses a randomized controlled trial design to compare cold water immersion, warm water immersion, and a control treatment to provide clearer evidence on effective recovery methods. Participants will be randomly assigned to one of three groups: cold water immersion, where they submerge their lower limbs in 10-12°C water for 15 minutes; warm water immersion, with lower limbs immersed in 40°C water for 15 minutes; or simulated laser therapy as a control, where a device mimics treatment without active laser output. Each treatment is given one hour after exercise, then repeated at 24 and 48 hours. The exercise protocol involves drop jumps to induce muscle soreness. During the study, participants undergo baseline measurements including body composition, muscle stiffness, range of motion, pain levels, and blood tests. Follow-up assessments and blood samples are collected before each intervention and at 24, 48, 72, and 96 hours post-exercise. The main outcome is the change in muscle soreness measured by a pain scale up to 72 hours post-exercise. Additional measures include muscle strength, biochemical markers of muscle damage, tissue elasticity, and inflammation. The study is conducted over several weeks with monitoring to assess recovery progress.
CONDITIONS
Brief Title
Cold Vs Warm Water Immersion for DOMS Recovery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy males aged 18 to 25 years
- Body Mass Index (BMI) between 18.5 and 30 kg/m²
- Muscle pain greater than 5 on the Visual Analog Scale (VAS) within 12 to 30 hours after exercise
- Engage in moderate physical activity for 2 to 5 hours per week
- Willing to sign informed consent approved by an ethics committee
You will not qualify if you...
- Inflammatory diseases within the past 6 months
- Neurological disorders affecting muscle strength
- Current use of steroids, analgesics, muscle relaxants, or other specified medications
- Unstable medical conditions including cardiovascular, respiratory, gastrointestinal, metabolic, endocrine, kidney, urinary tract, genetic, nervous system, or mental health issues
- History of alcohol or drug abuse in the past year
- Unwillingness to follow study guidelines or considered unsuitable by researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo baseline assessments including body composition, joint range of motion, muscle stiffness, pain evaluation, and blood sampling after fasting and a light meal.
1 visit (in-person)
Duration - 1 day
Participants perform eccentric exercises designed to induce muscle soreness under supervision of physiotherapists.
1 visit (in-person)
Duration - 3 days
Participants receive their assigned intervention: cold water immersion, hot water immersion, or simulated laser therapy, following exercise-induced muscle damage.
3 visits (in-person) occurring at 1 hour, 24 hours, and 48 hours post-exercise
Duration - 4 days
Participants undergo functional tests and blood sampling to assess recovery and muscle soreness up to 96 hours post-exercise.
4 visits (in-person) at 24, 48, 72, and 96 hours post-exercise
Trial Site Locations
Total: 1 location
1
Akademia Wychowania Fizycznego w Warszawie
Biała Podlaska, Lublin Voivodeship, Poland, 21-500
Actively Recruiting
Research Team
S
Szczepan Wiecha
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here